Zentiva

Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 16, Status: Authorised

Retrieved on: 
Friday, January 5, 2024
Medical Subject Headings, Marketing, European Commission, Agency, Neuropathic pain, INN, Risk, ATC, Capsule, International, European, Spinal cord, Language, Butyric acid, Brain, Anxiety disorder, Anxiety, GAD, Nervous, Peripheral neuropathy, Zentiva, Select, Committee, Patient, Risk management, Anatomy, Medicine, IIA, CHMP, Medical device

Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 16, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 16, Status: Authorised

ZENTIVA PRESENTS STRONG ESG PROGRESS IN SUSTAINABILITY REPORT 2022

Retrieved on: 
Tuesday, August 1, 2023
Carbon accounting, Sustainability reporting, Partner, Public, Waste management, Tree, Carbon, History, Equity, Sustainable Development Goals, Creativity, United Nations Global Compact, GRI, Diversity, HR, Communication, Biophysical environment, Inclusion, ESG, Czech, Environment, Nursing, Renewable energy, Zentiva

With sustainability embedded into its business strategy, the company fulfilled its 2022 sustainability goals and implemented actions in 3 pillars: People, Partners and Planet.

Key Points: 
  • With sustainability embedded into its business strategy, the company fulfilled its 2022 sustainability goals and implemented actions in 3 pillars: People, Partners and Planet.
  • Steffen Saltofte, CEO Zentiva: "Zentiva continues to make a significant contribution to public health in Europe.
  • Zentiva's 2022 Sustainability Report discloses the non-financial topics referencing GRI standards and presents first time a verified carbon footprint analysis as well for Scope 3 emissions.
  • The company presents an ambitious outlook for 2023, showing full commitment to further progress in all areas of ESG.

ZENTIVA PRESENTS STRONG ESG PROGRESS IN SUSTAINABILITY REPORT 2022

Retrieved on: 
Tuesday, August 1, 2023
Carbon accounting, Sustainability reporting, Partner, Public, Waste management, Tree, Carbon, History, Equity, Sustainable Development Goals, Creativity, United Nations Global Compact, GRI, Diversity, HR, Communication, Biophysical environment, Inclusion, ESG, Czech, Environment, Nursing, Renewable energy, Zentiva

With sustainability embedded into its business strategy, the company fulfilled its 2022 sustainability goals and implemented actions in 3 pillars: People, Partners and Planet.

Key Points: 
  • With sustainability embedded into its business strategy, the company fulfilled its 2022 sustainability goals and implemented actions in 3 pillars: People, Partners and Planet.
  • Steffen Saltofte, CEO Zentiva: "Zentiva continues to make a significant contribution to public health in Europe.
  • Zentiva's 2022 Sustainability Report discloses the non-financial topics referencing GRI standards and presents first time a verified carbon footprint analysis as well for Scope 3 emissions.
  • The company presents an ambitious outlook for 2023, showing full commitment to further progress in all areas of ESG.

STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA

Retrieved on: 
Tuesday, April 18, 2023
Acceleration, Health, Management, Zentiva

PRAGUE, April 18, 2023 /PRNewswire/ -- Zentiva is pleased to announce the appointment of Steffen Saltofte to the role of Chief Executive Officer (CEO), succeeding Nick Haggar who moves to the Zentiva Advisory Committee as a non-executive member.

Key Points: 
  • PRAGUE, April 18, 2023 /PRNewswire/ -- Zentiva is pleased to announce the appointment of Steffen Saltofte to the role of Chief Executive Officer (CEO), succeeding Nick Haggar who moves to the Zentiva Advisory Committee as a non-executive member.
  • Steffen Saltofte joins from Acino, where he was CEO from 2018 until 2022.
  • Steffen Saltofte commented: "I am excited to be joining Zentiva, a company with a strong track record in business growth and customer focus.
  • The Zentiva Advisory Committee, shareholders and employees wish to thank Nick Haggar for his leadership during the last four years as CEO.

ZENTIVA COMMITS TO PLANT 1 MILLION TREES BY 2030

Retrieved on: 
Tuesday, March 21, 2023
International, International Day of Forests, Partner, Waste management, Communication, Tree, Carbon, Sustainability, Forest, Water, HR, Environment, CO2, Renewable energy, Zentiva, Biodiversity

PRAGUE, March 21, 2023 /PRNewswire/ -- Zentiva today celebrates the International Day of Forests by committing to plant 1 million trees by 2030. Being a producer of high-quality and affordable medicines, Zentiva is generating carbon emissions and is aware of its impact on the environment. That is why the company committed to a strong sustainability program as part of its business strategy.  

Key Points: 
  • PRAGUE, March 21, 2023 /PRNewswire/ -- Zentiva today celebrates the International Day of Forests by committing to plant 1 million trees by 2030.
  • Being a producer of high-quality and affordable medicines, Zentiva is generating carbon emissions and is aware of its impact on the environment.
  • Nick Haggar, CEO of Zentiva: "At Zentiva, we ensure medicines supply and more than 100 million people in Europe and beyond trust in our products.
  • Since then, the company has already planted more than 250.000 trees as part of its reforestation and offsetting program.

The number of promising young scientists is increasing, Zentiva has awarded them for the fifth time

Retrieved on: 
Tuesday, February 28, 2023
Research and development, Student, Attention, Employment, Czech Republic, Sport, Nursing, Management, Research, PARC, Zentiva, Education

Students and their supervisors selected the best projects in the field of applied medical research and development.

Key Points: 
  • Students and their supervisors selected the best projects in the field of applied medical research and development.
  • The Parc has grown over the past year, and 32 students are currently studying for an industrial doctorate there.
  • PhD students from The Parc were awarded The Parc Awards in two categories.
  • During the existence of the center, they have had more than 30 patents, more than 100 scientific publications and many prestigious awards.

Zentiva extends its collaboration with Adalvo and strengthens its offering in Respiratory, CNS and Dermatology

Retrieved on: 
Monday, January 9, 2023
Corporate Affairs, Patient, Partnership, Pharmacist, Physician, Zentiva, CNS, Dermatology

The products are indicated in a variety of therapeutical areas like Respiratory, CNS and Dermatology.

Key Points: 
  • The products are indicated in a variety of therapeutical areas like Respiratory, CNS and Dermatology.
  • Sona Porubska, Head of Corporate Affairs and Strategic Franchises: "At Zentiva, we are delighted to further complement our product offering with the support of longstanding partners like Adalvo with new molecules in Respiratory, CNS and Dermatology.
  • Anil Okay, CEO at Adalvo comments: "We are thrilled to further strengthen our partnership with Zentiva, one of the largest multinational pharma players in Europe.
  • Our longstanding history of collaboration, paired with Zentiva remarkable commercialization capabilities, will ensure that our differentiated portfolio offering reaches more patients throughout Europe".

ACTING NOW FOR A SUSTAINABLE FUTURE: Publication of Zentiva's 1st Sustainability Report

Retrieved on: 
Thursday, October 6, 2022
People, Physician, HR, Biophysical environment, Communication, Efficiency, Growth, Partner, ESG, Diversity, Patient, Carbon, Investment, Partnership, Biodiversity, Learning, Industry, CEO, Water, Minister of Diversity, Inclusion and Youth, Pharmacist, Solution, Public health, Renewable energy, Management, Zentiva

Zentiva celebrates its 4th anniversary of independence and step by step the company framed its sustainability around 3 pillars: People, Partners and our Planet.

Key Points: 
  • Zentiva celebrates its 4th anniversary of independence and step by step the company framed its sustainability around 3 pillars: People, Partners and our Planet.
  • "Zentiva already has many strengths but our work shows significant scope to reduce waste, increase efficiency and to drive our growth in an even more sustainable manner.
  • As a team, we have discussed the importance of judging our performance and actions today against the standards of tomorrow.
  • I believe that people and the topic of sustainability must go hand in hand to get things moving.

ACTING NOW FOR A SUSTAINABLE FUTURE: Publication of Zentiva's 1st Sustainability Report

Retrieved on: 
Thursday, October 6, 2022
People, Physician, HR, Biophysical environment, Communication, Efficiency, Growth, Partner, ESG, Diversity, Patient, Carbon, Investment, Partnership, Biodiversity, Learning, Industry, CEO, Water, Minister of Diversity, Inclusion and Youth, Pharmacist, Solution, Public health, Renewable energy, Management, Zentiva

Zentiva celebrates its 4th anniversary of independence and step by step the company framed its sustainability around 3 pillars: People, Partners and our Planet.

Key Points: 
  • Zentiva celebrates its 4th anniversary of independence and step by step the company framed its sustainability around 3 pillars: People, Partners and our Planet.
  • "Zentiva already has many strengths but our work shows significant scope to reduce waste, increase efficiency and to drive our growth in an even more sustainable manner.
  • As a team, we have discussed the importance of judging our performance and actions today against the standards of tomorrow.
  • I believe that people and the topic of sustainability must go hand in hand to get things moving.

The fourth ORBIS School enhancing international collaboration on pharmaceutical innovations was held in Prague

Retrieved on: 
Friday, September 16, 2022
University, Czech Republic, Development, D, Czech Technical University in Prague, Poznań University of Medical Sciences, Knowledge, Partnership, University of Chemistry and Technology, Prague, Industry, Program, Patient, Medicine, Physician, ORBIS, Pharmacist, The Orbis School, Solution, Technology, Pharmacy, University of Helsinki, School, Research, Motivation, R, Horizon, Pharmaceutical industry, EU, Zentiva

PRAGUE, Sept. 16, 2022 /PRNewswire/ -- Between 7th and 9th September, the fourth ORBIS School was held in Prague.

Key Points: 
  • PRAGUE, Sept. 16, 2022 /PRNewswire/ -- Between 7th and 9th September, the fourth ORBIS School was held in Prague.
  • ORBIS (Open Research Biopharmaceutical Internships Support) is an international project which is a part of the EU program HORIZON 2020, focused on research and development.
  • ORBIS is a platform that unites universities, research institutes, and pharmaceutical companies from several European countries.
  • Participants from Ireland, France, Finland, Germany, Poland and Ukraine came to Prague for the ORBIS School.